GIIS012-Grupo de estudio de enfermedad de Gaucher y neoplasias hematológicas

Andrade-Campos M, Capablo J, Fraile J, Roca-Espiau M, Irun P, Cebolla J, de Frutos L, Arenaz I, Villarrubia J, Barez A, Cano H, Molero T, Villalon L, Giraldo P. Twenty-Five Years Diagnosing Gaucher's Disease in Spain, What We Have Learned?. Blood. 2018. 132. 10.1182/blood-2018-99-115474.

Andrade-Campos M, Cebolla J, de Frutos L, Irun P, Noya S, Nieto S, Villalon L, Arribas A, Barez A, Garcia-Frade J, Hermosin M, Hernandez-Rivas J, Ibarretxe D, Lozano M, Molero T, Perez-Saenz M, Villarrubia J, Giraldo P. Prospective National-Base Multicenter Study to Standardize the Follow-up of Type 1Gaucher Disease Patients Treated with Eliglustat Under Standard of Care Practice. Trazelga Project. Blood. 2018. 132. 10.1182/blood-2018-99-115534.

Gracia R, Yus C, Abian O, Mendoza G, Irusta S, Sebastian V, Andreu V, Arruebo M. Enzyme structure and function protection from gastrointestinal degradation using enteric coatings. Int. J. Biol. Macromol.. 2018. 119: 413 - 422. 10.1016/j.ijbiomac.2018.07.143.

de Frutos L, Lahoz-Gil C, Almeida A, Alfonso P, Giraldo P. GENOTYPING CYTOCHROME CYP2D6 IN TYPE I GAUCHER DISEASE PATIENTS. Haematologica. 2018. 103: 148 - 149. .

de Frutos L, Lahoz-Gil C, de Aranibar F, de Toledo L, Giraldo P. DESCRIPTION OF A NEW VARIANT ASSOCIATED WITH CUTANEOUS PORPHYRIA. Haematologica. 2018. 103: 151 - 151. .

Casado L, Garcia-Ormena N, Mba C, Garcia-Gutierrez J, Giraldo P, Perez-Encinas M, De Paz R, Ayala R, Bautista G, Osorio S, Requena M, Palomera L, Penarrubia M, Calle C, Hernandez-Rivas J, Steegmann J. ANALYSIS OF DEEP MOLECULAR RESPONSES ACHIEVED BY THE MULTIPLE SEQUENCES OF TREATMENTS WITH ITKS IN LMC. LONG FOLLOW-UP STUDY OF THE LMC SPANISH REGISTRY. Haematologica. 2018. 103: 231 - 231. .

Alejo T, Andreu V, Mendoza G, Sebastian V, Arruebo M. Controlled release of bupivacaine using hybrid thermoresponsive nanoparticles activated via photothermal heating. J. Colloid Interface Sci.. 2018. 523: 234 - 244. 10.1016/j.jcis.2018.03.107.

Manas-Martinez A, Bucar-Barjud M, Campos-Fernandez J, Gimeno-Orna J, Perez-Calvo J, Ocon-Breton J. Association of positive screening for dysphagia with nutritional status and long-term mortality in hospitalized elderly patients. Endocrinol. Diabetes Nutr.. 2018. 65(7): 402 - 408. 10.1016/j.endinu.2018.02.004.

Garcia-Campayo J, Lopez del Hoyo Y, Barcelo-Soler A, Navarro-Gil M, Borao L, Giarin V, Tovar-Garcia R, Montero-Marin J. Exploring the Wisdom Structure: Validation of the Spanish New Short Three-Dimensional Wisdom Scale (3D-WS) and Its Explanatory Power on Psychological Health-Related Variables. Front. Psychol.. 2018. 9: 692. 10.3389/fpsyg.2018.00692.

Noya M, Andrade-Campos M, Irun P, de Frutos L, Lopez-Fernandez M, Giraldo P. Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously. Clin. Case Rep.. 2018. 6(5): 887 - 892. 10.1002/ccr3.1460.

de Frutos L, Cebolla J, Irun P, Kohler R, Giraldo P. The erythrocyte osmotic resistance test as screening tool for cholesterol-related lysosomal storage diseases. Clin Chim Acta. 2018. 480: 161 - 165. 10.1016/j.cca.2018.02.010.

Frejo L, Gallego-Martinez A, Requena T, Martin-Sanz E, Amor-Dorado J, Soto-Varela A, Santos-Perez S, Espinosa-Sanchez J, Batuecas-Caletrio A, Aran I, Fraile J, Rossi-Izquierdo M, Lopez-Escamez J. Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease. Sci Rep. 2018. 8: 5974. 10.1038/s41598-018-23911-4.

Prieto E, Vispe E, De Martino A, Idoipe M, Rodrigo M, Garcia-Martin E, Fraile J, Polo-Llorens V, Mayoral J. Safety study of intravitreal and suprachoroidal Laponite clay in rabbit eyes. Graefes Arch. Clin. Exp. Ophthalmol.. 2018. 256(3): 535 - 546. 10.1007/s00417-017-3893-5.

Mendoza G, de Solorzano I, Pintre I, Garcia-Salinas S, Sebastian V, Andreu V, Gimeno M, Arruebo M. Near infrared dye-labelled polymeric micro- and nanomaterials: in vivo imaging and evaluation of their local persistence. Nanoscale. 2018. 10(6): 2970 - 2982. 10.1039/c7nr07345c.

Alejo T, Prieto M, Garcia-Juan H, Andreu V, Mendoza G, Sebastian V, Arruebo M. A facile method for the controlled polymerization of biocompatible and thermoresponsive oligo(ethylene glycol) methyl ether methacrylate copolymers. Polym. J.. 2018. 50(2): 203 - 211. 10.1038/s41428-017-0004-8.

Giraldo P, Andrade-Campos M, Alfonso P, Irun P, Atutxa K, Acedo A, Barez A, Blanes M, Diaz-Morant V, Fernandez-Galan M, Franco R, Gil-Cortes C, Giner V, Ibanez A, Latre P, Loyola I, Luno E, Hernandez-Martin R, Medrano-Engay B, Puerta J, Roig I, de la Serna J, Salamero O, Villalon L, Pocovi M. Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project. Blood Cells Mol. Dis.. 2018. 68: 173 - 179. 10.1016/j.bcmd.2016.10.017.

Andrade-Campos M, Valero E, Roca M, Giraldo P, Spanish Grp Gaucher Dis. The utility of magnetic resonance imaging for bone involvement in Gaucher disease. Assessing more than bone crises. Blood Cells Mol. Dis.. 2018. 68: 126 - 134. 10.1016/j.bcmd.2016.10.004.

Zimran A, Belmatoug N, Bembi B, Deegan P, Elstein D, Fernandez-Sasso D, Giraldo P, Goker-Alpan O, Lau H, Lukina E, Panahloo Z, Schwartz I, GOS Study Grp. Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS). Am. J. Hematol.. 2018. 93(2): 205 - 212. 10.1002/ajh.24957.

Zimran A, Gonzalez-Rodriguez D, Abrahamov A, Cooper P, Varughese S, Giraldo P, Petakov M, Tan E, Chertkoff R. Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naive or previously treated with imiglucerase. Blood Cells Mol. Dis.. 2018. 68: 163 - 172. 10.1016/j.bcmd.2016.10.005.

Biegstraaten M, Cox T, Belmatoug N, Berger M, Collin-Histed T, Dahl S, Di Rocco M, Fraga C, Giona F, Giraldo P, Hasanhodzic M, Hughes D, Iversen P, Kiewiet A, Lukina E, Machaczka M, Marinakis T, Mengel E, Pastores G, Plockinger U, Rosenbaum H, Serratrice C, Symeonidis A, Szer J, Timmerman J, Tylki-Szymanska A, Hubshman M, Zafeiriou D, Zimran A, Hollak C. Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease. Blood Cells Mol. Dis.. 2018. 68: 203 - 208. 10.1016/j.bcmd.2016.10.008.

Deegan P, Fernandez-Sasso D, Giraldo P, Lau H, Panahloo Z, Zimran A. Treatment patterns from 647 patients with Gaucher disease: An analysis from the Gaucher Outcome Survey. Blood Cells Mol. Dis.. 2018. 68: 218 - 225. 10.1016/j.bcmd.2016.10.014.

de Frutos L, Cebolla J, Irun P, Kohler R, Giraldo P. Erythrocyte osmotic resistance test as a screening tool for lysosomal diseases. Mol. Genet. Metab.. 2018. 123(2): 89 - 89. 10.1016/j.ymgme.2017.12.229.

de Frutosa L, Cebolla J, Irun P, Giraldo P. Discovery study for new genetic variants related to Niemann-Pick disease type C. Mol. Genet. Metab.. 2018. 123(2): 88 - 88. 10.1016/j.ymgme.2017.12.228.

Andreu V, Arruebo M. Current progress and challenges of nanoparticle-based therapeutics in pain management. J. Control. Release. 2018. 269: 189 - 213. 10.1016/j.jconrel.2017.11.018.

Olivan-Viguera A, Garcia-Otin A, Lozano-Gerona J, Abarca-Lachen E, Garcia-Malinis A, Hamilton K, Gilaberte Y, Pueyo E, Kohler R. Pharmacological activation of TRPV4 produces immediate cell damage and induction of apoptosis in human melanoma cells and HaCaT keratinocytes. PLoS One. 2018. 13(1): e0190307. 10.1371/journal.pone.0190307.